articleLeukemiaSep 15, 2015Closed access

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

DSDaniel SommermeyerMHMichael HudecekPLPaula L. KosasihTGTea GogishviliDGDavid G. Maloney

Fred Hutch Cancer Center · University of Würzburg · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

853
total citations
FWCI
23.38
Percentile
100%
References
295
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Cytotoxic T cell
  • Chimeric antigen receptor
  • CD8
  • T cell
  • In vivo
  • CD19
  • Biology
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding